By Tom Adams

California’s legal cannabis market may have finally found its bottom. Sales rose 7.8% in the first half of 2026, to $2.6 billion from $2.4 billion, the first gain after four straight years of decline that left the market 16.6% below its 2021 peak, according to BDSA. The turn did not come out of the blue — the annual decline had already narrowed to 2.1% in 2025, the mildest year of the bust.

The boom-bust cycle is not just a California story, and the top line of every other western market is still shrinking — Nevada down 9.2%, Colorado 6.7%, Arizona 5.4%, Oregon 2.8% and New Mexico 1.4% in the same half — while the newer markets east of the Mississippi have barely begun the descent California is climbing out of. A few recent launches like Minnesota are still booming. California is not different from these markets, just four to six years ahead of them (see table).

Source: Tom Adams Research analysis of BDSA data (Cannabis Market Forecasts, April 2026).

Its four-year slide and apparent recovery point to the industry’s central strategic question: what stops a newly legal market from growing, and what brings growth back? Hanging in the balance is a legal market that threatens to stall near $31 billion in national sales, well below the $51 billion the illicit market was producing when Colorado opened the legal era in 2014. Whether the licensed market ever overtakes the one it was built to replace hinges on the lessons California is learning now.

The price was never real

Cannabis 101 is a history class, starting with a unit on pricing. It’s a free market, so California dispensaries sold an ounce of flower for as much as $340 in the early years, near what the street charged. Operators hoped to keep the robust prices the legacy market commanded while shedding the legal risk that justified them. It just wasn’t going to happen.

There was never a hard cost basis for those prices. Consumers, through their local dealers, had paid legacy growers a premium for the risk they ran to their property, freedom and lives — not for the cost of the crop. RAND estimated in 2010 that a legal pound would cost $200 to $400 to grow indoors, against illicit weed then wholesaling for $2,000 to $8,000 (depending on how far from the NorCal grows it had to travel) and predicted legal prices would fall “quite possibly a full order of magnitude.”

They did, and everywhere on about the same schedule. Colorado and Oregon opened their adult-use markets near $2,000 a pound (in 2014 and 2015). Within three to four years each had crashed below $1,000 — Colorado to $880 by 2018, Oregon to $844 — and wholesale prices have bounced along that floor since, according to tracking by Cannabis Benchmarks. Every subsequent adult-use market — including California (see graph) — launched with wholesale pounds between $1,500 and $2,000 and gave the premium back within a few years, especially to the bulk buyers that pull down the weighted averages. Strategic planners have largely internalized that painful early lesson.

Source: Cannabis Benchmarks® / New Leaf Data Services.

The shakeout continues

The second lesson is trickier. Going in, growers know that adult-use legalization will feature a brief window of short supply, pricing power, and profitability. Then wholesale prices will fall to cost-plus-a-thin-margin, as any commodity does. If you couldn’t expect a floor to develop, you’d be crazy to invest in a new state (and probably smart to hurry out of the ones you’re already in).

The California experience suggests wholesale prices do stop plummeting once supply constricts — and California’s supply chain has been constricting for almost three years. At retail, active licenses have dropped nearly every quarter since peaking near 1,932 at the end of 2023, to 1,740 by early 2026; and closures accelerated as the bust deepened — ceased sites peaked at 77 in the last quarter of 2024. But the carnage at retail is easing up: ceased sites fell to just 15 in the first quarter of 2026, the fewest on record against 60 a year earlier.

The cultivation field thinned even harder: Humboldt County alone has lost more than 1,400 legal grow sites. Over half its remaining growers are behind on their local taxes. We’ll see if this first-half uptick in consumer spending comes soon enough to save some of them.

Retail revenue turns positive as price pressure eases a bit

Here is what the price pain buys. Cheaper cannabis sells more of it, and California’s five-year price collapse drove an explosion in units: combined pre-roll sales more than doubled and vape volume rose more than tenfold from 2020 to 2025, with edibles climbing too (see graph). That growth is now cooling — pre-rolls up 12% in the latest half against a 16%-a-year compound annual growth rate 2020-2025, vape up 9% against 64% — but that is still growth other consumer product sectors only dream about. Raw flower continues to shrink, but total inhalable-unit sales rose 5.5% in the half, after a 13.4% five-year CAGR.

Source: Tom Adams Research analysis of DCC data — California DCC “Sales and Price per Unit” dashboard.

The shrinking share of raw flower is a positive for the licensed channel. The overall volume data makes it clear consumers are not abandoning cannabis, and that it is simply a matter of changing consumer preferences (“What are we, cowboys?” I suggested to National Geographic last year when they wondered what was behind the shift away from rolling your own). The shift actually reflects the industry’s successful product development efforts, which will stand it in good stead in the continuing competition with illicit and hemp-based markets.

The price slide that facilitated all the volume growth is now doing what is typical in a bottoming market: decelerating. The steep high-single-digit annual retail declines of the bust have given way to low single-digit drops across most categories (see graph), while wholesale has ground along its sub-$1,000 floor for years. Deceleration on both sides — volume up and price down — is a classic sign of a product category transitioning out of its boom-bust early days.

Source: Tom Adams Research analysis of DCC data — California DCC “Sales and Price per Unit” dashboard.

The recovery has a guest list

Of course, the first-half uptick could still prove to be a dead-cat bounce. Oregon, after all, shrank 20% from its 2021 peak through 2023, posted a 1.1% gain in 2024, then dropped 3.6% in 2025, and 2.8% so far in 2026. Colorado hasn’t posted an annual gain since it peaked in 2021, was down 41% by 2025 and shrank another 6.7% in the first half of 2026. Nevada has shrunk 31% during the same stanza and is down almost 10% so far this year.

Or California may continue to recover but other markets continue to shrink. In the Golden State, the licensed market’s competitive position against its rivals — hemp-derived and illicit — is strengthening. Legal California flower now sells for about $63 an ounce at retail — less than a fifth of the $350 to $400 that illicit sinsemilla commanded in 2010. The illegality premium is not merely shrinking at the counter and the farm gate; it is largely gone.

So, the illicit market that still commands 63% of California cannabis sales is no longer defended by a massive price advantage, just the modest one granted it by state regulators with the high taxes and regulatory costs they impose on the licensed pipeline. What protects the illicit market now is access, not price: most local jurisdictions still refuse to license a storefront. Meantime, legal operations have borrowed the CPG playbook and have scale and efficiency on their side. Any time state and local governing bodies unleash them, battle-hardened licensed operators are in position to eliminate the illicit trade the way the professionally run liquor channel finally got rid of bootlegging in the 1960s.

As California goes?

The competitor that could recede fastest, though, isn’t the illicit trade but the hemp pipeline. California spent 2025 beginning to clear intoxicating hemp from store shelves — first ingestibles, after the state’s September 2024 emergency regulations, then the inhalable vapes and pre-rolls that compete most directly with licensed product, as AB 8 passed last fall. That the biggest first-half volume spikes show up in exactly those formats is suggestive of what a November national ban on intoxicating hemp could do elsewhere.

The bust California appears to be exiting is not a verdict on the industry. It is a stage, and everybody gets a turn. The “end-is-near” fatalism that has haunted the sector since the COVID spike and subsequent downturn did valuable work puncturing the sky’s-the-limit balloon of the 2010s, but it has outlived its usefulness in strategic and investment planning.

What four years destroyed in California was unrealistic pricing, not the market — and the $24 billion hemp-derived cannabinoid market that exploded across the country while dispensary sales fell in mature states is all the evidence anyone needs that demand never left the category, only the licensed channel (see Investors Are Reading the Wrong Tape). Every high-growth market I’ve studied runs this cycle: demand explosion, then oversupply and desperate price competition, then company attrition until the survivors finally have room to make money.

California has finished paying for the illusion that legal markets could command illicit-market prices; the eastern states are just making a down payment on the steep tuition. But the first-half upturn in California holds out the promise of gainful employment after graduation for operators in the licensed cannabis trade across the country.

TOM ADAMS is President & Principal Analyst at Tom Adams Research, where he publishes monthly Insights on the worldwide cannabis industry. The most experienced strategic consultant in legal cannabis, he was founder of Adams Media Research, head of Industry Intelligence at BDSA, and editor of the Arcview/BDSA State of Legal Cannabis Markets annual reports. Subscribe to the monthly Insight at adamsresearch.net or reach Tom at tom@adamsresearch.net.